Prevalence of KRAS, NRAS and BRAF mutations detected by massive parallel sequencing and differential clinical outcome in metastatic colorectal cancer (MCRC) patients (pts) treated with first line FIr-B/FOx adding bevacizumab (BEV) to triplet chemotherapy
PDF的下载单位、IP信息已删除
(2025-6-4)
BowieHuang
无极微光
幽壑之潜蛟
你嵙这个期刊没买
Twonej
Criminology34
smottom
eric888
CAOHOU
toutou
轨迹
猪猪hero
快乐滑板
pluto
专注的问寒
沉默的倔驴
耍酷的卿
pcr163
CassieBotelho
Mic
tuanheqi
拉哈80
YifanWang
萝卜
皖公网安备34019202002308
